Name: #108 IT: Deloitte (ConvergeHEALTH) Innovation Theater: Automating Adverse Event Case Processing Through Machine Learning and Innovation
Start: 2021-06-28T12:30:00-0400
End: 2021-06-28T13:00:00-0400

Back To Schedule

#108 IT: Deloitte (ConvergeHEALTH) Innovation Theater: Automating Adverse Event Case Processing Through Machine Learning and Innovation

Component Type: Session
Level: Intermediate

Adverse Event (AE) collection, assessment and reporting is a foundational activity of Sanofi’s pharmacovigilance and license to operate. With 600K+ AE cases expected annually, it is an intensive, manual, expensive, and time-consuming activity. Hear about Sanofi’s success with case processing automation via natural language processing, machine learning and artificial intelligence with Deloitte’s ConvergeHEALTH Safety Cognitive Platform. And the benefits of using cloud-based automation technology.

Chair

Deloitte

Speakers

Amanda Kirby Bowles

Managing Director, Deloitte, United States

Amanda Bowles has over 14 years of life sciences experience including over 10 years specializing as a pharmacovigilance and drug safety systems subject matter advisor. Amanda has in depth experience in drug safety, pharmacovigilance and regulatory affairs, including extensive experience... Read More →

Glenn Carroll

Principal, Deloitte, United States

Glenn Carroll is a principal in our life science strategy practice with over 15 years pharmaceutical and biotech experience. Glenn leads Deloitte's US Safety and Medical practices. He has a strong track record in delivering strategic and operational excellence, specifically in the... Read More →